WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03B VITAMIN B12 AND FOLIC ACID

B03BA Vitamin B12 (cyanocobalamin and analogues)

Hydroxocobalamin for treatment of neuralgia is classified here.
Combinations with liver extract are classified at separate 5th levels using the corresponding 50-series. Combinations with folic acid are classified in this group by using the 50-series.

Vitamin B12, see also:

A11D - Vitamin B1, plain and in combination with vitamin B6 and B12
A11EA - Vitamin B-complex, plain
B03A - Iron preparations



The DDDs are based on maintenance treatment of pernicious anemia. Different DDDs are assigned for oral and parenteral formulations of cyanocobalamin due to great differences in bioavailability.

The DDD for mecobalamin is based on the treatment of peripheral neuropathies.

B03BB Folic acid and derivatives

Folic acid and derivatives in combination with other substances are classified in this group at separate 5th levels using the corresponding 50-series, if folic acid deficiency is the main indication. Folinates, used as antidotes, are classified in V03A. Combinations with iron, see B03AD and B03AE.

Combinations with vitamin B12 are classified in B03BA.

The DDD for oral folic acid is based on prophylactic use and the parenteral DDD is based on treatment.

Last updated: 2013-12-19